Literature DB >> 35796739

Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial.

Minoodokht Bavarsadkarimi1, Sirous Omidi2, Farinaz Shahmoradi3, Zahra Heidar4, Sahar Mirzaei5.   

Abstract

This is a randomized controlled trial conducted in a tertiary referral fertility department. Participants were women with previous poor ovarian response undergoing in vitro fertilization. (IVF). One hundred and ninety-two women were randomized to the short GnRH agonist and antagonist regimens. The primary outcome was the number of oocytes retrieved. Secondary outcome measures were the number of embryos transferred, chemical and clinical pregnancy rate and live birth. The number of oocytes retrieved was higher with the gonadotrophin-releasing hormone (GnRH) antagonist regimen compared to the short agonist regimen (3.10 2.70 vs. 2.992.60), but there was no significant difference. The duration of stimulation and total gonadotropin dose were higher with short agonist regimens compared to antagonist regimens, with the latter being statistically significant (p < 0.001). The chemical pregnancy rate was 8.33 percent with the short agonist regimen and 7.29 percent with the antagonist regimen, with no statistically significant difference (p = 0.79). In terms of lower cycles cancelation and higher chemical pregnancy, short GnRH agonist regim is appropriate choice for poor responders.

Entities:  

Year:  2022        PMID: 35796739      PMCID: PMC9580530          DOI: 10.4081/ejtm.2022.10634

Source DB:  PubMed          Journal:  Eur J Transl Myol        ISSN: 2037-7452


  35 in total

Review 1.  Assisted conception following poor ovarian response to gonadotrophin stimulation.

Authors:  S D Keay; N H Liversedge; R S Mathur; J M Jenkins
Journal:  Br J Obstet Gynaecol       Date:  1997-05

Review 2.  Gonadotropin-releasing-hormone-receptor antagonists.

Authors:  J A Huirne; C B Lambalk
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

3.  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.

Authors:  A P Ferraretti; A La Marca; B C J M Fauser; B Tarlatzis; G Nargund; L Gianaroli
Journal:  Hum Reprod       Date:  2011-04-19       Impact factor: 6.918

Review 4.  Aspirin for in vitro fertilisation.

Authors:  Charalampos S Siristatidis; George Basios; Vasilios Pergialiotis; Paraskevi Vogiatzi
Journal:  Cochrane Database Syst Rev       Date:  2016-11-03

5.  Agonist "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment.

Authors:  Kamel A Mohamed; W A R Davies; Julian Allsopp; Hany Lashen
Journal:  Fertil Steril       Date:  2005-02       Impact factor: 7.329

6.  Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles.

Authors:  Ulun Ulug; Izhar Ben-Shlomo; Ersadik Turan; Halit Firat Erden; Mehmet Ali Akman; Mustafa Bahceci
Journal:  Reprod Biomed Online       Date:  2003-06       Impact factor: 3.828

7.  Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels.

Authors:  Judith A F Huirne; Andre C D van Loenen; Roel Schats; Joseph McDonnell; Peter G A Hompes; Joop Schoemaker; Roy Homburg; Cornelis B Lambalk
Journal:  Hum Reprod       Date:  2004-08-27       Impact factor: 6.918

8.  Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.

Authors:  Korhan Kahraman; Bulent Berker; Cem Somer Atabekoglu; Murat Sonmezer; Esra Cetinkaya; Rusen Aytac; Hakan Satiroglu
Journal:  Fertil Steril       Date:  2008-06-13       Impact factor: 7.329

9.  Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.

Authors:  Sesh Kamal Sunkara; Arri Coomarasamy; Raef Faris; Peter Braude; Yacoub Khalaf
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

10.  The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.

Authors:  Xue-Li Li; Li Wang; Fang Lv; Xia-Man Huang; Li-Ping Wang; Yu Pan; Xiao-Mei Zhang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.